Publication:
Synthesis of Quinoline and Dihydroquinoline Embelin Derivatives as Cardioprotective Agents

dc.contributor.authorMartín-Acosta, Pedro
dc.contributor.authorCuadrado, Irene
dc.contributor.authorGonzález-Cofrade, Laura
dc.contributor.authorPestano, Roberto
dc.contributor.authorHortelano, Sonsoles
dc.contributor.authorde Las Heras, Beatriz
dc.contributor.authorEstévez-Braun, Ana
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.contributor.funderAgencia Canaria de Investigación, Innovación y Sociedad de la Información
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderInstituto de Salud Carlos III
dc.date.accessioned2023-05-24T07:58:51Z
dc.date.available2023-05-24T07:58:51Z
dc.date.issued2023-02-24
dc.description.abstractA set of new dihydroquinoline embelin derivatives was obtained from the reaction of the natural benzoquinone embelin (1) with anilines and aromatic aldehydes in the presence of AgOTf. The synthesis of these compounds involves the formation of a Knoevenagel adduct, followed by nucleophilic addition of aniline and subsequent electrocyclic ring closure. The scope of the reaction regarding the aldehydes and anilines was determined. Quinoline derivatives were also obtained from the corresponding dihydroquinolines under oxidation with DDQ. The cardioprotective activity of the synthesized compounds was screened using a doxorubicin-induced cardiotoxicity model in H9c2 cardiomyocytes. Some structure-activity relationships were outlined, and the best activities were achieved with quinoline-embelin derivatives having a 4-nitrophenyl group attached at the pyridine ring. The obtained results indicated that embelin derivatives 4i, 6a, 6d, 6k, and 6m could have potential as cardioprotective agents, as they attenuated a DOX-induced cardiotoxicity effect acting on oxidative stress and apoptosis.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipWe gratefully acknowledge the financial support from the Spanish MICIU RTI2018-094356-B-C21 to A.E.B., I.C., and B.H. and Agencia Canaria de Investigación, Innovación y Sociedad de la Información Pro ID 2021010037 to A.E.B. These projects are also cofunded by the European Regional Development Fund (FEDER). We thank Dr. A. Tapia and G. Feresin for providing the natural embeline. We are grateful to Instituto de Salud Carlos III for financial support to S.H.es_ES
dc.format.number2es_ES
dc.format.page317-329es_ES
dc.format.volume86es_ES
dc.identifier.citationJ Nat Prod. 2023 Feb 24;86(2):317-329.es_ES
dc.identifier.doi10.1021/acs.jnatprod.2c00924es_ES
dc.identifier.e-issn1520-6025es_ES
dc.identifier.journalJournal of natural productses_ES
dc.identifier.pubmedID36749898es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16113
dc.language.isoenges_ES
dc.publisherACS Publications
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RTI2018-094356-B-C21es_ES
dc.relation.publisherversionhttps://doi.org/10.1021/acs.jnatprod.2c00924es_ES
dc.repisalud.centroISCIII::Instituto de Investigación de Enfermedades Raras (IIER)es_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshCardiotonic Agentses_ES
dc.subject.meshQuinolineses_ES
dc.subject.meshHumanses_ES
dc.subject.meshCardiotoxicityes_ES
dc.subject.meshDoxorubicines_ES
dc.subject.meshBenzoquinoneses_ES
dc.subject.meshOxidative Stresses_ES
dc.subject.meshMyocytes, Cardiaces_ES
dc.subject.meshApoptosises_ES
dc.subject.meshAniline Compoundses_ES
dc.subject.meshAldehydeses_ES
dc.titleSynthesis of Quinoline and Dihydroquinoline Embelin Derivatives as Cardioprotective Agentses_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicatione8434c4f-9d6e-418c-ba38-a3728163d52b
relation.isAuthorOfPublication.latestForDiscoverye8434c4f-9d6e-418c-ba38-a3728163d52b
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication2e7d9b6e-e96e-48e3-9d51-0bcdd5167de5
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication.latestForDiscovery289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isPublisherOfPublicationbbe00a75-ae1f-41b0-8a37-df183dabf093
relation.isPublisherOfPublication.latestForDiscoverybbe00a75-ae1f-41b0-8a37-df183dabf093

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
SynthesisQuinolineDihydroquinolineEmbelin_2023.pdf
Size:
3.79 MB
Format:
Adobe Portable Document Format
Description: